Informatie:
Fout:
ID
34324
Beschrijving
Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience; ODM derived from: https://clinicaltrials.gov/show/NCT02485262
Link
https://clinicaltrials.gov/show/NCT02485262
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatitis C NCT02485262
Eligibility Hepatitis C NCT02485262
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C NCT02485262
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
adult chronic hcv patients aged >18
boolean
ID.2
Item
treatment naïve
boolean
ID.3
Item
patient with cirrhosis and no cirrhosis. cirrhosis defined as stage 4 fibrosis on liver biopsy or fibro sure results indicating cirrhosis or has clinical findings suggestive of cirrhosis
boolean
ID.4
Item
patients meet the indication to receive one of the sof treatment based regimens
boolean
ID.5
Item
co-infected patients with hiv or hepatitis b
boolean
ID.6
Item
patient received one of the daas regimens
boolean
ID.7
Item
patient with active substance abuse and alcohol abuse
boolean
ID.8
Item
patient received prior daa regimen
boolean
ID.9
Item
decompensated cirrhotic patients
boolean
ID.10
Item
patient has contraindication to receive sof
boolean